Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6301 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
79-31        TRIJARDY XR Boehringer Ingelheim Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-32        TRIJARDY XR Boehringer Ingelheim Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-33        TRIJARDY XR Boehringer Ingelheim Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-34        TRIJARDY XR Boehringer Ingelheim Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-35        NOBELZIN Nobel Pharma Co., Ltd. (ノーベルファーマ株式会社) Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs
79-36        FROBEN Kaken Pharmaceutical Co., Ltd. (科研製薬株式会社) Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs
79-37        Xulane / MYLAN TECHNOLOGIES INC US Orange Book The 79th Batch of Reference Listed Drugs
79-38        Xulane / MYLAN TECHNOLOGIES INC US Orange Book The 79th Batch of Reference Listed Drugs
79-39        / ZYLA LIFE SCIENCES US INC Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-40        / N.V. Organon Original drug approved in China Original drug imported to China The 79th Batch of Reference Listed Drugs